Literature DB >> 9062774

Does medical treatment of mild intraocular hypertension prevent glaucoma?

I Aguinaga Ontoso1, F Guillen Grima, E Aguinaga Ontoso, L R Fernandez Fernandez.   

Abstract

Glaucoma is a serious disease that may cause a decrease in peripheral vision as well as blindness. Although the treatment of extreme levels of high intraocular pressure (p > 35 mm) reduces the risk of glaucoma it is not known if the treatment of mild and moderate intraocular pressure prevents the onset of glaucoma. A bibliographic search in Medline CD-ROM was performed from 1967 to 1995, as well as in SIGLE CD-ROM. The keywords used were 'glaucoma prevention' and 'glaucoma suspects'. After the search 18 papers which treated moderate and mild intraocular pressure were selected. Of all these papers, those that used the same methodology; randomization and timolol as treatment, were chosen. The possibility of publication bias was controlled by plotting effect size vs. number of papers, as well as effect size vs. year of publication. A meta-analysis using two methods, weighted zetas and adding zetas, was performed. The combined effect size was -6.25%, and the weighted effect size was -6.45%. We computed the pooled z by two methods: adding Zs and adding weighted Zs. The Z obtained by adding Zs has a value of 2.31120 p = 0.0177, one tail). Using the method of adding weighted Zs we obtained a value of 2.4201 (p = 0.0082, one tail). Our results show that the treatment with timolol of patients with mild and moderate intraocular pressure may help to prevent the onset of glaucoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062774     DOI: 10.1023/a:1007324907818

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  28 in total

1.  Prognostic factors in glaucomatous visual field loss.

Authors:  M A Kass; A E Kolker; B Becker
Journal:  Arch Ophthalmol       Date:  1976-08

2.  The time-course of intraocular pressure in timolol-treated and untreated glaucoma suspects.

Authors:  B C Chauhan; S M Drance; G R Douglas
Journal:  Am J Ophthalmol       Date:  1989-05-15       Impact factor: 5.258

3.  Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.

Authors:  J M Tielsch; A Sommer; J Katz; R M Royall; H A Quigley; J Javitt
Journal:  JAMA       Date:  1991-07-17       Impact factor: 56.272

4.  Ocular hypertension--a long-term follow-up of treated and untreated patients.

Authors:  R David; D G Livingston; M H Luntz
Journal:  Br J Ophthalmol       Date:  1977-11       Impact factor: 4.638

5.  A study of the intraocular pressure lowering effect of timolol and dipivalyl epinephrine.

Authors:  K D Frumar; R McGuinness
Journal:  Trans Ophthalmol Soc N Z       Date:  1981

6.  Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

Authors:  M A Kass
Journal:  Trans Am Ophthalmol Soc       Date:  1989

7.  Why do some people go blind from glaucoma?

Authors:  W M Grant; J F Burke
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

8.  Manifest glaucoma in the aged I: occurrence nine years after a population survey.

Authors:  B Bengtsson
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-06

9.  Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.

Authors:  A Sommer; J M Tielsch; J Katz; H A Quigley; J D Gottsch; J Javitt; K Singh
Journal:  Arch Ophthalmol       Date:  1991-08

Review 10.  Prevalence of myopia in open angle glaucoma.

Authors:  L Mastropasqua; L Lobefalo; A Mancini; M Ciancaglini; S Palma
Journal:  Eur J Ophthalmol       Date:  1992 Jan-Mar       Impact factor: 1.922

View more
  2 in total

1.  Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.

Authors:  W Y Zhang; A L Po; H S Dua; A Azuara-Blanco
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 2.  Medical interventions for primary open angle glaucoma and ocular hypertension.

Authors:  C Vass; C Hirn; T Sycha; O Findl; P Bauer; L Schmetterer
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.